MedTrace Logo

Minocycline and Aspirin in the Treatment of Bipolar Depression

NCT01429272 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2018-01-11

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether minocycline and aspirin are effective in the treatment of depression in individuals with bipolar disorder.

Conditions

  • Bipolar Disorder Depression

Interventions

DRUG

Minocycline

100 mg po bid for 6 weeks

DRUG

Aspirin

81 mg po bid for 6 weeks

DRUG

placebo

placebo for minocycline and/or aspirin

Sponsors & Collaborators

  • Stanley Medical Research Institute

    collaborator OTHER

  • University of Oklahoma

    collaborator OTHER

  • Laureate Institute for Brain Research, Inc.

    lead OTHER

Principal Investigators

  • Sheldon Preskorn, MD · Laureate Institute for Brain Research, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2015-08-31
Completion
2015-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01429272 on ClinicalTrials.gov